HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by COOKSON, J. Search for Related Content PubMed PubMed Citation Articles by COOKSON, J.

Use of antipsychotic drugs and lithium in mania

The Royal London Hospital, London, UK

Correspondence: Dr John Cookson, The Royal London Hospital, St Clement's, 2a Bow Road, London E3 4LL, UK. Tel: +44 (0)20 7377 7957; fax: +44 (0)20 7377 7963; e-mail: cookson-psychiatry{at}mcmail.com

Declaration of interest J.C. has lectured and been a member of advisory panels for Janssen, Eli Lilly and Glaxo Wellcome. He has also run funded trials of risperidone, olanzapine and lamotrigine.

Background Studies highlighting the difficulties associated with lithium suggest that the role of antipsychotic drugs and mood stabilisers in bipolar disorder should be reconsidered.

Aims To review the efficacy and mode of action of antipsychotic drugs in mania, and to consider the differences between official guidelines and routine clinical practice in the use of these agents for mania.

Method Review of research, guideline-and practice-based literature.

Results Guidelines recommend lithium or valproate as first-line treatments for mania, and antipsychotic agents only as ‘adjuncts’ for agitation, dangerous behaviour or psychosis. However, in routine practice, antipsychotic drugs are often prescribed. The effectiveness of these agents in mania has been established by several studies; newer atypical compounds demonstrate antimanic efficacy with a reduced incidence of neurological side-effects.

Conclusion Antipsychotic drugs are important in the treatment of bipolar disorder and mania. Future studies should evaluate the long-term efficacy and safety of newer atypical antipsychotic agents, and the place of anticonvulsants in combination with antipsychotics in bipolar disorder.